FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma.
Milewski, D; Shukla, S; Gryder, BE; Pradhan, A; Donovan, J; Sudha, P; Vallabh, S; Pyros, A; Xu, Y; Barski, A; et al.
Oncogene.
2021;
40:2182-2199.
Reply to comment on: Solitary myofibroma preceding the development of multicentric myofibromatosis: A report of two cases with surveillance recommendations.
Turpin, B; Todd, KE; Pressey, JG.
Pediatric Blood and Cancer.
2020;
67.
Solitary myofibroma preceding the development of multicentric myofibromatosis: A report of two cases with surveillance recommendations.
Todd, K; Kim, HK; Szabo, S; Johnson, S; Pressey, J; Nagarajan, R; Sorger, J; Dasgupta, R; Turpin, B.
Pediatric Blood and Cancer.
2020;
67.
Can a children's hospital still cut it? Comparing outcomes of pediatric, adolescent and young adult patients undergoing thoracic surgery for lung metastases.
Scorletti, F; Cooke-Barber, J; Pressey, JG; Nagarajan, R; Turpin, B; Jenkins, T; Dasgupta, R.
Pediatric Blood and Cancer.
2020;
67.
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung.
Baird, K; Glod, J; Steinberg, SM; Reinke, D; Pressey, JG; Mascarenhas, L; Federman, N; Marina, N; Chawla, S; Lagmay, JP; et al.
Sarcoma.
2020;
2020.
Paediatric ganciclovir dosing in extracorporeal membrane oxygenation: Is standard dosing good enough?.
Murphy, M; Chamberlain, A; Tang, P; Turpin, B; Danziger-Isakov, L.
Journal of Clinical Pharmacy and Therapeutics.
2020;
45:218-220.
Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients.
Dandoy, CE; Kelley, T; Gaur, AH; Nagarajan, R; Demmel, K; Alonso, PB; Guinipero, T; Savelli, S; Hakim, H; Owings, A; et al.
Pediatric Blood and Cancer.
2019;
66.
Common Secondary Genomic Variants Associated With Advanced Epithelioid Hemangioendothelioma.
Seligson, ND; Awasthi, A; Millis, SZ; Turpin, BK; Meyer, CF; Grand'Maison, A; Liebner, DA; Hays, JL; Chen, JL.
JAMA Network Open.
2019;
2.
Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016).
Widemann, BC; Lu, Y; Reinke, D; Okuno, SH; Meyer, CF; Cote, GM; Chugh, R; Milhem, MM; Hirbe, AC; Kim, A; et al.
Sarcoma.
2019;
2019.
Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal Tumors.
Davis, JL; Lockwood, CM; Stohr, B; Boecking, C; Al-Ibraheemi, A; DuBois, SG; Vargas, SO; Black, JO; Cox, MC; Luquette, M; et al.
American Journal of Surgical Pathology.
2019;
43:435-445.